Pharmacyte Biotech Inc (OTCMKTS:PMCB) provided an update on the status of the compliance process for Austrianova’s cGMP facility in Thailand. In this GMP facility, the genetically tailored human cells will be encapsulated in innovative Cell-in-a-Box® capsules that Pharmacyte intends to use in clinical studies targeting diabetes and cancer.
As per the report, Austrianova is steadily moving forward to complete operational qualification and, performance and installation prerequisite on the clean room and linked regions. It is also applicable on the machines needed to complete the manufacturing process at the facility. Pharmacyte reported that the audit is completed by an expert who has an extensive experience of over fifteen years in the Pharma industry.
Cerebain Biotech Corp (OTCBB:CBBT) Obtains Financial Commitment
Cerebain Biotech Corp (OTCBB:CBBT) reported that it obtained financial commitment worth $2 million. This will allow company to pursue its designed corporate development plans. Also, they finalized a contract with GMEA to acquire up to $1.6 million shares of company’s stock. The funds raised from the deal will be utilized to boost business and financial development plans that will further assist the company advance with its testing and research programs.
Eric Clemons, the President and CEO said that they are working to create a research platform in an entirely new way to the therapy of Alzheimer’s disease. There has never been such a increased demand for effective treatments, as incidences of this indiscriminate and deadly killer is projected to grow sharply in the next 25 years.
Celgene Corporation (NASDAQ:CELG) Updates On Acquisition Deal
Celgene Corporation (NASDAQ:CELG) disclosed they have concluded acquisition of firm Receptos Inc (NASDAQ:RCPT). The compensation to Receptos stockholders amounted to $232 per share in cash, with the total consideration coming at approximately $7.2 billion. Following the completion of deal, Receptos stock will no longer trade on the NASDAQ platform, after market close on August 27, 2015.